Home » Newsletters » BioWorld Science

BioWorld Science

June 5, 2000

View Archived Issues

Abgenix and SB sign agreement for XenoMouse technology collaboration

Combination of psycho- and drug therapy most efficacious for chronic depression

Cellular aging reversed in calves cloned from senescent cells

Ortec completes patient enrollment in CCS pivotal donor site study

Lilly and Scios extend Alzheimer's research collaboration

Oxford BioMedica extends exclusive access to cytochrome P-450 enzymes

Vectura and Chiesi to develop further HFA pMDIs

Tularik and Japan Tobacco announce third alliance

IGT Pharma compound neuroprotective in vitro

Preliminary results reported for Forbes Medi-Tech's new cholesterol-lowering agent

Enrollment completed in phase III trial of Oxygent

Avanir's NDA for docosanol deemed approvable by FDA

3M's QVAR asthma inhaler approved by Health Canada

Activity of ABT-773 against anaerobic bacteria and pneumococci

Clinical pharmacokinetics of voriconazole with and without loading doses

INSIGHT study establishes once-daily Adalat as first-line therapy for higher risk hypertension

PNA antisense molecules demonstrate antibacterial activity in vitro

Medarex and Biosite establish drug research alliance

Efficacy, safety and PK of fozivudine tidoxil assessed in phase II trial in HIV-infected patients

Schering AG's Yasmin approved in The Netherlands

Scientists at BASF design new thrombin muteins as antidotes to thrombin inhibitors

New heterocyclic compounds from Takeda stimulate thermogenesis

Modulators of PPAR receptors useful for metabolic disorders in the Ono pipeline

Aventis presents new inhibitors of IL-1beta production and their use

HGS discovers new member of the FGF receptor family of proteins

GM-95: a novel antitumor antibiotic produced by Streptomyces

Inhibitors of Na+/H+ exchange remain a focus of research at Aventis

Toa Eiyo describes new thiazolidine-based selective chymase inhibitors

Novel somatostatin receptor modulators synthesized at Takeda

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...